Evidence map›Paper›PMID 35747583›Full record

ReviewJournal of ophthalmology2022

Myopia: Mechanisms and Strategies to Slow Down Its Progression.

Andrea Russo, Alessandro Boldini, Davide Romano, Giuseppina Mazza, Stefano Bignotti, Francesco Morescalchi, Francesco Semeraro

Open access · goldAbstract readReview
In one paragraph

Review in Journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of spectacle lenses specifically designed for myopia control: systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Visual outcomes of implantable Collamer lens and laser-assistedInternational journal of ophthalmology · 2026
    Article
  7. Article
  8. Article
  9. Management of myopia: a mini-review.Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
  10. Atropine Eye Drops in Childhood Myopia Control: A Review.International journal of medical sciences · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Optical influence of myopia control spectacles at the retinal level: Effect of local light modulation.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrea RussoEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.ORCID https://orcid.org/0000-0002-1566-3662
Alessandro BoldiniEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.ORCID https://orcid.org/0000-0002-2169-4035
Davide RomanoEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.
Giuseppina MazzaEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.
Stefano BignottiEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.
Francesco MorescalchiEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.
Francesco SemeraroEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, Italy.
University of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This topical review aimed to update and clarify the behavioral, pharmacological, surgical, and optical strategies that are currently available to prevent and reduce myopia progression. Myopia is the commonest ocular abnormality; reinstated interest is associated with high and increasing prevalence, especially but not, in the Asian population and progressive nature in children. The growing global prevalence seems to be associated with both genetic and environmental factors such as spending more time indoor and using digital devices, particularly during the coronavirus disease 2019 pandemic. Various options have been assessed to prevent or reduce myopia progression in children. In this review, we assess the effects of several types of measures, including spending more time outdoor, optical interventions such as the bifocal/progressive spectacle lenses, soft bifocal/multifocal/extended depth of focus/orthokeratology contact lenses, refractive surgery, and pharmacological treatments. All these options for controlling myopia progression in children have various degrees of efficacy. Atropine, orthokeratology/peripheral defocus contact and spectacle lenses, bifocal or progressive addition spectacles, and increased outdoor activities have been associated with the highest, moderate, and lower efficacies, respectively.

Identifiers

PMID35747583
PMCPMC9213207
OpenAlexW4282933577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.